Tecnologia em Saúde
Empresas Suíças envolvidas em um setor: tecnologia em saúde
Essas Empresas Suíças atuam no mesmo setor, tecnologia em saúde. Cada uma inclui estatísticas importantes como preço da ação, variação diária e volume de negociação para ajudar você a tomar decisões mais informadas. Seja acompanhando gigantes do setor como Eli Lilly and Company ou observando os maiores volumes como Novartis AG, esta lista oferece insights valiosos para qualquer estratégia de negociação. Filtre e compare empresas e mantenha-se por dentro das tendências do mercado com facilidade.
Símbolo | Valor de mercado | Preço | Variação % | Volume | Volume Rel | P/L | EPS dil TTM | Crescimento EPS dil. 12M Ano a Ano | Div. yield % TTM | Classificação dos Analistas |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 737,96 B CHF | 802,669 CHF | +2,07% | 63 | 3,91 | 44,82 | 17,91 CHF | +71,63% | 0,62% | Viés de alta |
| LLYEli Lilly and Company | 737,96 B CHF | 800 CHF | −11,11% | 12 | 1,25 | 44,67 | 17,91 CHF | +71,63% | 0,62% | Viés de alta |
 JNJ.USDJohnson & Johnson | 460,79 B CHF | 140,67 USD | 0,00% | 650 | 1,64 | 12,74 | 8,76 CHF | +90,53% | 2,12% | Viés de alta |
| JNJJohnson & Johnson | 460,79 B CHF | 193,57 CHF | +4,86% | 1 | 0,00 | 22,11 | 8,76 CHF | +66,31% | 2,12% | Viés de alta |
| JNJJohnson & Johnson | 460,79 B CHF | 190,226 CHF | −1,36% | 45 | 3,17 | 21,72 | 8,76 CHF | +66,31% | 2,12% | Viés de alta |
 4ABAbbVie, Inc. | 325,53 B CHF | 173,817 CHF | −3,65% | 25 | 0,25 | 92,85 | 1,87 CHF | −13,81% | 2,82% | Viés de alta |
 RHO5Roche Holding Ltd Dividend Right Cert. | 287,17 B CHF | 351,377 CHF | −2,03% | 805 | 0,62 | 21,91 | 16,04 CHF | +55,42% | 2,70% | Viés de alta |
| RHORoche Holding Ltd | 287,17 B CHF | 373,892 CHF | +2,18% | 24 | 0,41 | 23,31 | 16,04 CHF | +55,42% | 2,60% | Viés de alta |
| RORoche Holding Ltd | 287,17 B CHF | 362,2 CHF | −2,74% | 19,76 K | 0,45 | 22,58 | 16,04 CHF | +55,42% | 2,60% | Viés de alta |
| ROGRoche Holding Ltd Dividend Right Cert. | 287,17 B CHF | 351,5 CHF | −2,03% | 1,08 M | 0,89 | 21,91 | 16,04 CHF | +55,42% | 2,70% | Viés de alta |
 ZEGAstraZeneca PLC | 243,85 B CHF | 155,653 CHF | +2,22% | 112 | 5,02 | 29,25 | 5,32 CHF | +32,54% | 1,57% | Viés de alta |
 NOVNEENovartis AG TEMP | 243 B CHF | 125,16 CHF | −2,31% | 180 K | 1,00 | 21,00 | 5,96 CHF | +15,19% | 2,74% | Sem classificação |
| NOTNovartis AG | 243 B CHF | 124,856 CHF | −2,69% | 1,76 K | 0,88 | 20,94 | 5,96 CHF | +15,19% | 2,74% | Neutro |
| NOVNNovartis AG | 243 B CHF | 124,82 CHF | −2,24% | 3,52 M | 0,93 | 20,94 | 5,96 CHF | +15,19% | 2,74% | Neutro |
 MRK.USDMerck & Co., Inc. | 231,8 B CHF | 75,35 USD | 0,00% | 190 | 0,44 | 10,36 | 5,77 CHF | +8,04% | 2,73% | Viés de alta |
| 6MKMerck & Co., Inc. | 231,8 B CHF | 92,961 CHF | −1,99% | 2 | 0,03 | 16,12 | 5,77 CHF | −5,69% | 2,73% | Viés de alta |
 AMGAmgen Inc. | 159,37 B CHF | 297,390 CHF | +1,95% | 3 | 0,15 | 26,36 | 11,28 CHF | +64,64% | 2,55% | Viés de alta |
 ABLAbbott Laboratories | 153,19 B CHF | 88,504 CHF | −0,21% | 3 | 0,08 | 30,03 | 2,95 CHF | −57,65% | 2,12% | Viés de alta |
| ABTAbbott Laboratories | 153,19 B CHF | 88,0 CHF | −12,00% | 10 | 0,27 | 29,86 | 2,95 CHF | −57,65% | 2,12% | Viés de alta |
 TN8Thermo Fisher Scientific Inc. | 148,46 B CHF | 401,333 CHF | +1,23% | 50 | 6,17 | 28,54 | 14,06 CHF | −6,29% | 0,34% | Viés de alta forte |
 GISGilead Sciences, Inc. | 143,43 B CHF | 115,243 CHF | −3,96% | 13 | 0,19 | 21,43 | 5,38 CHF | +1.512,72% | 2,13% | Viés de alta |
 IUI1Intuitive Surgical, Inc. | 138,74 B CHF | 392,147 CHF | +3,60% | 1 | 0,06 | 62,80 | 6,24 CHF | +7,20% | 0,00% | Viés de alta |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 132,04 B CHF | 29,384 CHF | −30,39% | 100 | — | 10,69 | 2,75 CHF | −7,78% | 3,20% | Viés de alta |
| NOVNovo Nordisk A/S Class B | 132,04 B CHF | 30,107 CHF | +1,14% | 1,28 K | 0,23 | 10,52 | 2,86 CHF | +0,57% | 4,75% | Viés de alta |
 PFEPfizer Inc. | 117,99 B CHF | 20,680 CHF | −0,52% | 20 | 0,05 | 19,25 | 1,07 CHF | −15,91% | 6,46% | Neutro |
 SYKStryker Corporation | 113,92 B CHF | 301,202 CHF | −0,30% | 20 | 1,03 | 45,24 | 6,66 CHF | −5,58% | 0,89% | Viés de alta |
 BRMBristol-Myers Squibb Company | 98,94 B CHF | 47,716 CHF | +1,72% | 74 | 0,13 | 17,40 | 2,74 CHF | — | 3,99% | Viés de alta |
 ESLEssilorLuxottica SA | 91,88 B CHF | 211,214 CHF | −3,29% | 20 | 0,54 | 45,55 | 4,64 CHF | −3,82% | 1,80% | Viés de alta forte |
 GS71GSK plc | 88,35 B CHF | 22,769 CHF | +0,77% | 2 | 0,00 | 15,34 | 1,48 CHF | +109,15% | 3,12% | Neutro |
 SNWSanofi SA | 87,01 B CHF | 70,671 CHF | −0,98% | 150 | 2,63 | 17,84 | 3,96 CHF | −4,80% | 4,95% | Viés de alta |
 BSXBoston Scientific Corporation | 83,52 B CHF | 56,916 CHF | −3,55% | 100 | 0,70 | 37,02 | 1,54 CHF | +35,69% | 0,00% | Viés de alta forte |
 RGORegeneron Pharmaceuticals, Inc. | 64,88 B CHF | 601,892 CHF | +1,03% | 10 | 0,90 | 18,27 | 32,95 CHF | −5,24% | 0,45% | Viés de alta |
 MRKMerck KGaA | 48,51 B CHF | 116,102 CHF | −0,28% | 70 | 1,13 | 18,27 | 6,35 CHF | +8,61% | 1,79% | Viés de alta |
 UNCUCB S.A. | 45,32 B CHF | 249,241 CHF | −4,02% | 100 | 0,62 | 33,36 | 7,47 CHF | +45,15% | 0,37% | Viés de alta |
 SHLSiemens Healthineers AG | 41,89 B CHF | 36,718 CHF | +0,27% | 11 | 0,08 | 20,91 | 1,76 CHF | +5,66% | 2,41% | Viés de alta |
| SHLSiemens Healthineers AG | 41,89 B CHF | 38,89 CHF | 0,00% | 365 | 0,04 | 22,14 | 1,76 CHF | +5,66% | 2,41% | Viés de alta |
 ZTS.USDZoetis, Inc. Class A | 41,45 B CHF | 126,21 USD | 0,00% | 46 | — | 20,96 | 4,77 CHF | +10,17% | 1,61% | Viés de alta |
 EW.USDEdwards Lifesciences Corporation | 38,58 B CHF | 86,420 USD | — | 57 | — | 47,84 | 1,43 CHF | +23,90% | 0,00% | Viés de alta |
 LONNLonza Group AG | 35,82 B CHF | 514,6 CHF | −2,09% | 131,09 K | 0,89 | 38,09 | 13,51 CHF | +51,44% | 0,76% | Viés de alta forte |
| LO3Lonza Group AG | 35,82 B CHF | 517,082 CHF | −1,96% | 305 | 1,91 | 38,27 | 13,51 CHF | +51,44% | 0,76% | Viés de alta forte |
 GALDGalderma Group AG | 34 B CHF | 154,788 CHF | +4,56% | 181 | 0,63 | 112,31 | 1,38 CHF | — | 0,10% | Viés de alta |
| GALDGalderma Group AG | 34 B CHF | 154,9 CHF | +6,98% | 768,93 K | 1,99 | 112,39 | 1,38 CHF | — | 0,10% | Viés de alta |
 BAYNBayer AG | 33,31 B CHF | 34,715 CHF | −9,36% | 1,79 K | 9,01 | — | −3,43 CHF | −40,48% | 0,29% | Viés de alta |
| BAYNBayer AG | 33,31 B CHF | 34,148 CHF | +0,23% | 655 | 2,01 | — | −3,43 CHF | −40,48% | 0,29% | Viés de alta |
 2U3Alcon AG | 32,6 B CHF | 64,448 CHF | −1,24% | 2,8 K | 0,75 | 38,85 | 1,66 CHF | −7,88% | 0,43% | Viés de alta |
| ALCAlcon AG | 32,6 B CHF | 64,38 CHF | −1,32% | 813,89 K | 0,60 | 38,81 | 1,66 CHF | −7,88% | 0,43% | Viés de alta |
 TEVTeva Pharmaceutical Industries Limited Sponsored ADRDR | 29,68 B CHF | 26,103 CHF | −4,76% | 11 | 0,01 | 27,05 | 0,97 CHF | — | 0,00% | Viés de alta forte |
 D8YSandoz Group Ltd | 29,22 B CHF | 65,021 CHF | −1,62% | 321 | 0,13 | 37,64 | 1,73 CHF | +35.889,58% | 0,90% | Viés de alta |
| SDZSandoz Group Ltd | 29,22 B CHF | 64,66 CHF | −2,62% | 796,65 K | 0,73 | 37,43 | 1,73 CHF | +35.889,58% | 0,90% | Viés de alta |
 L0TGE Healthcare Technologies Inc. | 28,07 B CHF | 62,059 CHF | −1,24% | 250 | 5,71 | 17,19 | 3,61 CHF | −8,44% | 0,18% | Viés de alta |
 PHI1Koninklijke Philips N.V. | 22,81 B CHF | 23,327 CHF | −4,50% | 256 | 7,44 | 26,89 | 0,87 CHF | — | 3,21% | Viés de alta |
 BIIBBiogen Inc. | 21,73 B CHF | 147,46 CHF | −36,44% | 1 | 0,00 | 21,12 | 6,98 CHF | −31,26% | 0,00% | Viés de alta |
| IDPBiogen Inc. | 21,73 B CHF | 145,926 CHF | −2,77% | 34 | 0,91 | 20,90 | 6,98 CHF | −31,26% | 0,00% | Viés de alta |
 22UABioNTech SE Sponsored ADRDR | 19,46 B CHF | 79,834 CHF | −1,03% | 7 | 0,11 | — | −2,09 CHF | −14,69% | 0,00% | Viés de alta forte |
 MRNA.USDModerna, Inc. | 17,79 B CHF | 49,49 USD | 0,00% | 2,2 K | 1,51 | — | −5,76 CHF | +21,77% | 0,00% | Neutro |
| 0QFModerna, Inc. | 17,79 B CHF | 44,439 CHF | +4,02% | 347 | 0,78 | — | −5,76 CHF | +31,72% | 0,00% | Neutro |
 ILUIllumina, Inc. | 15,37 B CHF | 102,354 CHF | +0,50% | 1 | 0,03 | 23,63 | 4,33 CHF | — | 0,00% | Viés de alta |
 QS51Straumann Holding AG | 14,06 B CHF | 85,468 CHF | −3,97% | 307 | 0,84 | 38,34 | 2,23 CHF | −8,00% | 1,08% | Viés de alta |
| STMNStraumann Holding AG | 14,06 B CHF | 84,88 CHF | −3,76% | 527,79 K | 1,29 | 38,07 | 2,23 CHF | −8,00% | 1,08% | Viés de alta |
 VTRSViatris, Inc. | 13,2 B CHF | 11,598 CHF | −6,67% | 15 | 0,07 | — | −2,35 CHF | −384,25% | 3,26% | Viés de alta |
 SOONSonova Holding AG | 11,69 B CHF | 192,0 CHF | −5,51% | 353,8 K | 2,00 | 22,04 | 8,71 CHF | −7,80% | 2,17% | Neutro |
| PHBNSonova Holding AG | 11,69 B CHF | 193,867 CHF | −4,89% | 104 | 0,34 | 22,26 | 8,71 CHF | −7,80% | 2,17% | Neutro |
 AFWAlign Technology, Inc. | 10,12 B CHF | 143,076 CHF | +8,12% | 30 | 0,74 | 31,89 | 4,49 CHF | −12,16% | 0,00% | Viés de alta |
 BM8BioMarin Pharmaceutical Inc. | 9,06 B CHF | 49,328 CHF | +6,09% | 1,8 K | 1,53 | 34,92 | 1,41 CHF | −29,28% | 0,00% | Viés de alta |
 BTLBaxter International Inc. | 7,63 B CHF | 16,066 CHF | +3,91% | 100 | 0,12 | — | −1,33 CHF | −15,25% | 1,89% | Neutro |
 RV7Halozyme Therapeutics, Inc. | 6,44 B CHF | 52,860 CHF | +7,11% | 1 K | 3,74 | 26,76 | 1,98 CHF | −36,64% | 0,00% | Viés de alta |
 GTNGetinge AB Class B | 4,6 B CHF | 16,754 CHF | −7,11% | 80 | 0,11 | 23,56 | 0,71 CHF | +44,66% | 2,31% | Viés de alta |
 1CGCRISPR Therapeutics AG | 4,49 B CHF | 46,240 CHF | +3,31% | 100 | 0,28 | — | −5,16 CHF | −30,46% | 0,00% | Viés de alta |
 BANBBachem Holding AG Class B | 4,38 B CHF | 57,85 CHF | −1,03% | 87,47 K | 0,50 | 32,32 | 1,79 CHF | +18,15% | 1,45% | Viés de alta |
| BANBBachem Holding AG Class B | 4,38 B CHF | 58,153 CHF | −0,15% | 45 | 0,20 | 32,49 | 1,79 CHF | +18,15% | 1,45% | Viés de alta |
 OWXYpsomed Holding AG | 3,78 B CHF | 279,485 CHF | +3,10% | 81 | 0,52 | 19,67 | 14,21 CHF | +160,77% | 0,79% | Viés de alta |
| YPSNYpsomed Holding AG | 3,78 B CHF | 274,5 CHF | −0,90% | 22,47 K | 0,80 | 19,32 | 14,21 CHF | +160,77% | 0,79% | Viés de alta |
 SFZNSiegfried Holding AG | 3,72 B CHF | 80,236 CHF | −2,37% | 45 | 0,12 | 20,84 | 3,85 CHF | +4,40% | 0,46% | Viés de alta |
| SFZNSiegfried Holding AG | 3,72 B CHF | 80,2 CHF | −2,79% | 90,19 K | 0,52 | 20,83 | 3,85 CHF | +4,40% | 0,46% | Viés de alta |
 FIEFielmann Group AG | 3,25 B CHF | 41,599 CHF | +3,21% | 150 | 0,84 | 22,04 | 1,89 CHF | — | 2,69% | Viés de alta |
 6MDMedacta Group SA | 3,16 B CHF | 155,086 CHF | +2,16% | 35 | 0,67 | 34,57 | 4,49 CHF | +65,90% | 0,44% | Viés de alta |
| MOVEMedacta Group SA | 3,16 B CHF | 157,2 CHF | −0,51% | 10,78 K | 0,68 | 35,04 | 4,49 CHF | +65,90% | 0,44% | Viés de alta |
 COTNCOMET Holding AG | 2,24 B CHF | 283,8 CHF | −1,32% | 26,46 K | 1,01 | 56,65 | 5,01 CHF | +122,39% | 0,52% | Viés de alta |
| EZP1COMET Holding AG | 2,24 B CHF | 284,198 CHF | −1,61% | 15 | 0,18 | 56,73 | 5,01 CHF | +122,39% | 0,52% | Viés de alta |
 AFXCarl Zeiss Meditec AG | 2,1 B CHF | 23,200 CHF | −3,85% | 100 | 0,37 | 15,39 | 1,51 CHF | −20,56% | 2,32% | Neutro |
 DMPDermapharm Holding SE | 1,88 B CHF | 34,519 CHF | −7,60% | 50 | 0,14 | 17,14 | 2,01 CHF | +26,88% | 2,34% | Viés de alta |
 COPNCosmo Pharmaceuticals NV | 1,84 B CHF | 108,6 CHF | −0,73% | 25,04 K | 0,81 | 35,03 | 3,10 CHF | −25,14% | 1,75% | Viés de alta forte |
 TENTecan Group AG | 1,68 B CHF | 132,508 CHF | +3,32% | 65 | 1,48 | 26,75 | 4,95 CHF | −37,23% | 2,30% | Viés de alta |
| TECNTecan Group AG | 1,68 B CHF | 130,4 CHF | −0,15% | 32,44 K | 0,70 | 26,32 | 4,95 CHF | −37,23% | 2,30% | Viés de alta |
 UP0Ultragenyx Pharmaceutical, Inc. | 1,64 B CHF | 17,698 CHF | −34,95% | 25 | — | — | −4,63 CHF | +19,61% | 0,00% | Viés de alta forte |
 IOVAIovance Biotherapeutics Inc | 1,37 B CHF | 3,011 CHF | +40,90% | 1,5 K | — | — | −0,89 CHF | +24,64% | 0,00% | Viés de alta |
 AB3ASarepta Therapeutics, Inc. | 1,32 B CHF | 12,867 CHF | −27,32% | 150 | 0,60 | — | −6,69 CHF | −409,03% | 0,00% | Neutro |
 38IIntellia Therapeutics, Inc. | 1,27 B CHF | 10,494 CHF | +1,86% | 496 | 0,51 | — | −3,03 CHF | +36,37% | 0,00% | Viés de alta |
 41XArdelyx, Inc. | 1,27 B CHF | 5,176 CHF | +18,96% | 3 K | 2,11 | — | −0,20 CHF | −33,61% | 0,00% | Viés de alta forte |
 NVV1Novavax, Inc. | 1,26 B CHF | 7,490 CHF | −1,73% | 600 | 1,12 | 3,97 | 1,89 CHF | — | 0,00% | Viés de alta |
 MEDMedartis Holding AG | 1,23 B CHF | 87,9 CHF | −2,22% | 3,24 K | 0,88 | — | −0,04 CHF | −112,70% | 0,00% | Viés de alta |
| 1RUMedartis Holding AG | 1,23 B CHF | 91,623 CHF | −0,06% | 3 | 0,04 | — | −0,04 CHF | −112,70% | 0,00% | Viés de alta |
 7VGSKAN Group AG | 1,16 B CHF | 52,180 CHF | −4,02% | 256 | 3,12 | 72,52 | 0,72 CHF | −49,82% | 0,78% | Viés de alta forte |
| SKANSKAN Group AG | 1,16 B CHF | 50,7 CHF | −1,36% | 34,26 K | 1,73 | 70,47 | 0,72 CHF | −49,82% | 0,78% | Viés de alta forte |
 KURNKuros Biosciences Ltd. | 1,07 B CHF | 27,24 CHF | −0,58% | 116,34 K | 1,02 | — | −0,16 CHF | +33,25% | 0,00% | Viés de alta forte |
| YTSNKuros Biosciences Ltd. | 1,07 B CHF | 25,748 CHF | +6,05% | 300 | 0,64 | — | −0,16 CHF | +33,25% | 0,00% | Viés de alta forte |
 IDIAIdorsia Ltd. | 947,82 M CHF | 3,660 CHF | −2,92% | 1,67 M | 0,91 | — | −0,54 CHF | +61,25% | 0,00% | Viés de alta |
| 19TIdorsia Ltd. | 947,82 M CHF | 4,083 CHF | +8,33% | 1,1 K | 0,53 | — | −0,54 CHF | +61,25% | 0,00% | Viés de alta |
 EVTEvotec SE | 910,3 M CHF | 5,048 CHF | +1,51% | 15 | 0,01 | — | −0,84 CHF | +8,27% | 0,00% | Viés de alta |
 PPGNPolyPeptide Group AG | 832,39 M CHF | 24,85 CHF | −1,39% | 24,17 K | 0,47 | — | −0,99 CHF | −19,29% | 0,00% | Viés de alta |